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Diabetes mellitus induces many pathophysiologic
changes in the skin. Even so, dermatologists still lack
an animal model of diabetes that enables the direct eva-
luation of the various functional properties of the skin.
Our group induced two types of an experimental type 1
diabetes model in hairless mice by administering either
streptozotocin or alloxan, in order to examine the
properties of the stratum corneum and epidermis of
these animals. The plasma glucose concentrations of
the mice at 3 wk after their i.v. injection were signi¢-
cantly higher than those of control mice (streptozoto-
cin, 3.2-fold; alloxan, 3.7-fold). The stratum corneum
water content was signi¢cantly reduced in both types
of diabetic mice, whereas the transepidermal water loss
remained unchanged. The amino acid content with
normal epidermal pro¢laggrin processing was either
normal or elevated in the stratum corneum of the strep-
tozotocin-treated mice. In contrast, the stratum cor-
neum triglyceride content in the streptozotocin-treated
mice was signi¢cantly lower than the control level, even
though the levels of ceramides, cholesterols, and fatty
acids in the stratum corneum were all higher than the
control levels.The streptozotocin-treated group also ex-
hibited decreases in basal cell proliferation and epider-
mal DNA content linked with an increase in the
number of corneocyte layers in the stratum corneum,
suggesting that the rates of epidermal and stratum cor-
neum turnover were slower in the streptozotocin-trea-
ted animals than in the normal controls. In contrast,
there were no remarkable changes in any of the epider-
mal di¡erentiation marker proteins examined. This
¢nding in diabetic mice, namely, reduction in both the
epidermal proliferation and stratum corneum water
content without any accompanying impairment in the
stratum corneum barrier function, is similar to that
found in aged human skin. Our new animal model
of diabetes will be useful for the study of diabetic der-
mopathy as well as the mechanisms of stratum cor-
neummoisturization. Key words: aging/horny layer/insulin/
loricrin. J Invest Dermatol 120:79 ^85, 2003
D
iabetes mellitus induces various forms of dermopa-
thy, for example, bullosis diabeticorum, necrobiosis
lipoidica diabeticorum, scleredema diabeticorum,
and acanthosis nigricans (Jelinek, 1993). All of these
skin conditions are derived from an impaired skin
homeostasis in the dermis and epidermis thought to be caused
either by diabetes-induced abnormalities of the metabolism or
by diabetic complications, such as vasculopathy and neuropathy.
Moreover, the insulin resistance and hyperglycemia in diabetes
have a con¢rmed involvement in the impaired functions ob-
served in various tissues of diabetic subjects. Hyperglycemia in-
duces cellular abnormalities via nonenzymatic glycation
processes, oxidative-reductive stress, aldose-reductase activation,
diacylglycerol-phosphate kinase C (PKC) activation, etc. (Koya
and King, 1998; Nishikawa et al, 2000). In the case of the skin,
diabetes is reported to induce advanced glycosylation end pro-
ducts in the collagen of the dermis (Kennedy and Baynes, 1984;
Sternberg et al, 1985), and these end products are postulated to
produce the characteristic sti¡ness (Aoki et al, 1993; Nikkels
Tassoudji et al, 1996) and thickness (Collier et al, 1989; Forst et al,
1994) of diabetic skin, as well as the delayed wound healing
observed in the disease (Brown et al, 1994; Franzen and Roberg,
1995; Bitar, 1998). Whereas no studies have been conducted to
identify the e¡ects of hyperglycemia on the epidermis, the im-
portance of insulin as an essential growth factor for cultured ker-
atinocytes and its substantial in£uence on their proliferation (Tsao
et al, 1982) and migration (Ando and Jensen, 1993; Benoliel et al,
1997) suggest that the inhibited keratinocyte proliferation in dia-
betic patients is an important factor in their delayed wound heal-
ing. In a more recent study,Wertheimer et al (2000) demonstrated
that insulin regulates the keratinocyte di¡erentiation. Nerve
growth factor is also involved in keratinocyte proliferation, and
epidermal basal cells in diabetic skin exhibit depressed genetic
expression of nerve growth factor in diabetes (Anand et al, 1996).
Interestingly, the surface area of corneocytes has been reported
to be larger in diabetic patients than in normal individuals
(Yajima et al, 1991), suggesting that diabetes mellitus may in£u-
ence the proliferation and di¡erentiation of keratinocytes. Little
is known, however, about the functional properties of the stra-
tum corneum (SC), the end product of the epidermis, in diabetes.
E¡orts to explore this have been hampered by the complicated
in£uences of age on the changes of the SC in diabetic patients.
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For example, it is di⁄cult to distinguish between the pruritus ob-
served in diabetes and that noted in senile xerosis by a simple
clinical observation (Jelinek, 1993).
In this study, we produced a new model of diabetic hairless
mice using streptozotocin or alloxan, agents well known to de-
stroy the insulin-secreting pancreatic b cells (Wilson and Leiter,
1990).We selected hairless mice because the presence of hair and
the hair cycle are known to disturb the functional and biochem-
ical analyses of the SC. Streptozotocin-treated animals are widely
used as a model of type I diabetes that exhibits many of the fea-
tures seen in human patients with uncontrolled diabetes mellitus,
including hyperglycemia, polydipsia, and polyuria (Tomlinson
et al, 1992; Cheta, 1998).
After inducing diabetes in the hairless mice using streptozoto-
cin or alloxan, we evaluated the hydration state and barrier func-
tion of the SC. In the streptozotocin group, we measured the
changes of the SC lipids and soluble amino acid content in the
SC.We found that the diabetic mice had impaired water home-
ostasis in the SC without any damage in the barrier function.The
SC amino acid and epidermal ¢laggrin levels were normal, but
the SC triglyceride levels were signi¢cantly lower than those
measured in controls. In addition, the epidermal turnover seemed
to be retarded in the streptozotocin group. Our experimental re-
sults suggested that SC hydration in the streptozotocin-induced
diabetic hairless mice may have been regulated by factors other
than intercellular lipids and amino acid levels (Horii et al, 1989;
Imokawa et al, 1991b), the major factors heretofore con¢rmed to
play a part in SC hydration.We con¢rmed that the experimen-
tally induced diabetic hairless mouse model is useful for the study
of not only the diabetic dermopathy, but also the mechanism of
SC hydration.
MATERIALS AND METHODS
Materials Male hairless mice (Hos/HR-1) were obtained from Hoshino
Laboratory Animals (Saitama, Japan). Streptozotocin was purchased from
Sigma (St Louis, MO). Alloxan monohydrate was purchased fromWako
(Osaka, Japan). Polyclonal antibodies against mouse ¢laggrin (AF 111),
keratin 1 (AF 109), keratin 5 (AF 138), and loricrin (AF 62) were purchased
from the Berkeley Antibody Company (Richmond, CA). Monoclonal
antibody against cytokeratin 10 (RKSE 60) was purchased from
MONOSAN (AM Uden, the Netherlands).
Induction of diabetes mellitus Male hairless mice (7 wk) were divided
into two groups: normal control mice and mice with experimentally
induced diabetes. Diabetes was induced in the streptozotocin group by a
single i.v. injection of streptozotocin (150 mg per kg of body weight)
dissolved in 50 mM citrate, pH 4.7. Diabetes was induced in the alloxan
group by a single i.v. injection of alloxan (45 mg per kg of body weight)
dissolved in 50 mM citrate, pH 4.7. Control mice were injected with citrate
bu¡er alone. The glucose content and transaminase (glutamic-oxaloacetic
transaminase, glutamic-pyruvic transaminase) activities, markers for
disorganization in blood plasma, were measured with a Glucose C II U
test kit (Wako, Osaka, Japan) and Transaminase C II U test kit (Wako),
respectively, according to the manufacturer’s instructions.
Measurements of SC hydration and transepidermal water loss
(TEWL) The state of SC hydration was determined by high-frequency
measurements of skin conductance. The skin conductance was determined
as the average values of ¢ve measurements taken with an impedance meter
(Skincon-200, IBS Co., Ltd, Hamamatsu, Japan) (Tagami et al, 1980).
TEWL was measured with a HYDROGRAPH (AMU-100, K and S,
Aichi, Japan), as described previously (Haratake et al, 1997).
Lipid content in the SC Punch biopsy skin specimens (diameter, 18
mm) were heat-split at 601C for 30 s to remove the intact epidermis. The
SC was isolated by £oating the epidermal sheets, basal side downward, on
0.5% trypsin in a phosphate-bu¡ered saline (PBS) for 2 h, and then
washing the sheets three times with PBS. SC lipids were extracted by the
method of Bligh and Dyer (1959), dried, weighed, and quanti¢ed by
fractionation using high-performance thin layer chromatography followed
by charring and scanning densitometry. Lipids were resolubilized in
chloroform/methanol (2 : 1 vol) and spotted on high-performance thin
layer chromatography plates (Merck, Darmstadt, Germany). For the
analysis of sebum-derived lipids, the plates were developed once in
benzene/hexane (1 : 1 vol) to 40 mm, then once in hexane/diethyl ether/
acetic acid (70 : 30 : 1 vol) to 80 mm. For measurement of ceramides, the
plates were developed once in chloroform/methanol/water (80 : 20 : 2 vol)
to 40 mm, once in chloroform/methanol/acetic acid (96 : 3.5 : 0.5 vol) to
64 mm, and once in hexane/diethyl ether/acetic acid (70 : 30 : 1 vol) to 80 mm.
After development, the plates were dipped in a charring solution [distilled
water containing 10% (w/v) copper sulfate and 8% (w/v) phosphoric acid],
dried, and incubated at 1801C for 15min.The plates were scanned and
quantitated using a densitometer (CS9300, Shimazu, Kyoto, Japan).
Oil red O staining Tissues ¢xed in formalin were dehydrated by a
sucrose solution, frozen, and sectioned. The frozen sections (6 mm) were
washed in water for 5 min and stained for 30 min (371C) with 1.8% (w/v)
oil red O solution [60% (v/v) isopropanol]. The sections were then washed
in water for another 5 min and counterstained for 2 min with hematoxylin.
Amino acid content in the SC SC sheets (2 cm 2 cm) were stripped
from the dorsal parts of the animals with 20 ml cyanoacrylate (Toa Kasei,
Tokyo, Japan) and OHP ¢lm sheet. Each SC sheet was divided into two
equal pieces (1 cm 2 cm) for quanti¢cation of SC amino acids and
weight. The sheets were extracted with 10 mM HCl by shaking (16 h) at
room temperature, and the extracts were applied to an amino acid
analyzer (L-8800, Hitachi, Tokyo, Japan) programmed to detect aspartic
acid, threonine, serine, asparagine, glutamic acid, glutamine, glycine,
alanine, citrulline, valine, methionine, isoleucine, leucine, tyrosine,
phenylalanine, ornithine, lysine, histidine, and arginine. The SC weight
was determined as described by Imokawa et al (1991a). Brie£y, the SC
sheets (1 cm 2 cm) were treated with dimethyl formamide under
ultrasonication for 30 min to solubilize cyanoacrylate resin. Dispersed SC
was separated through ¢ltration with a Millipore ¢lter (Millex-FH,
Bedford, MA). The ¢lters with SC were washed with dimethyl
formamide and methanol, dried at 401C for 2 d, and weighed.
Immunoblotting The epidermis was homogenized in a lysis bu¡er [0.1 M
Tris hydroxymethyl aminomethane^HCl (pH 9), 9 M urea, 1% 2-mercapto-
ethanol, 1% sodium dodecyl sulfate, 1 mM ethylenediamine tetraacetic acid,
and 0.1 mM phenylmethanesulfonyl £uoride] and centrifuged (15,000 g,
15 min). The supernatant was applied to immunoblotting.
The SC sheet stripped from the animal with cyanoacrylate (Toa Kasei,
Tokyo, Japan) was treated with dimethyl formamide to solubilize cyano-
acrylate resin, separated by centrifugation, and washed with PBS. The SC
extract was prepared with the lysis bu¡er. Bu¡er (2 mg per lane for
¢laggrin or 20 mg per lane for loricrin) was applied to electrophoresis on a
5^13% gradient sodium dodecyl sulfate^polyacrylamide gel, then transferred
electrophoretically to a polyvinylidene £uoride membrane (Polyscreen,
NEN Life Science Products, Inc., Boston, MA). After blocking of the
nonspeci¢c binding sites with 5% skim milk in PBS containing 0.1%
Tween 20, the membrane was incubated with corresponding antibodies in
the blocking bu¡er for 2 h at room temperature followed by washings
with PBS containing 0.5% Tween 20 (PBST). Next, the membrane was
incubated with the peroxidase-conjugated goat anti-mouse IgG (Hþ L)
antibody (ICN Biomedicals, Inc., Aurora, OH) or the peroxidase-
conjugated goat anti-rabbit immunoglobulin antibody (Dako Japan Co.,
Ltd, Kyoto, Japan) for 1 h. After washing with PBST, the membrane was
visualized using an enhanced chemiluminescence kit (SuperSignalWest Pico
Chemiluminescent Substrate, Pierce, Rockford, IL). The concentrations
of used primary antibodies were 1 : 10,000 (AF 111), 1 : 400,000 (AF 109),
1 : 100,000 (AF 138), 1 : 1000 (AF 62), and 1 : 500 (RKSE 60) for ¢laggrin,
keratin 1, keratin 5, loricrin, and keratin 10, respectively. The protein content
in the epidermis and SC was measured with a DC Protein Assay kit
(Bio-Rad Laboratories Inc., Richmond, CA).
Counting for proliferating cell nuclear antigen (PCNA)-positive
basal cells in the epidermis Skin specimens were ¢xed in 10%
formalin for 3 d, embedded in para⁄n, and cut in consecutive sections
measuring 3 mm in thickness. The sections were depara⁄nized in xylene and
rehydrated in a series of graded alcohols. After treatment with 3% hydrogen
peroxide, the sections were stained by an Auto Probe II kit (Biomeda, CA)
using anti-PCNA antibody (Biomeda, Foster City, CA). PCNA-positive
basal cells and total basal cells (200 cells per slide) were counted.
Epidermal DNA content Epidermal DNAwas extracted as described
by Moore (1999). Brie£y, epidermis prepared by the above method was
digested with proteinase K (0.2 mg per ml, 501C, 16 h) and extracted with
a phenol/chloroform/isoamyl alcohol solution (three times) to remove
protein contaminations. Next, the DNA solution was digested with
RNAase A (10 mg per ml, 371C, 2 h), extracted again with a phenol/
chloroform/isoamyl alcohol solution, precipitated with 100% ethanol, and
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washed with 70% ethanol. Concentrated DNA was re-solubilized with
water and quanti¢ed by measurement of the ultraviolet absorption.
Measurements of the corneocyte surface area Corneocytes were
collected by pressing a piece of low-strength adhesive tape (Suhada
Checker, Kanebo, Tokyo, Japan) against the skin. Tapes with corneocytes
were incubated in an eosin solution, washed with distilled water, and
dried. Microscopic images of 20 stained corneocytes were traced, and
their areas were binarized and measured by an image analyzer (Nexus
6800, Nexus, Tokyo, Japan). The average surface area of 20 corneocytes
was used as a representative value for each mouse.
Counting the number of corneocyte layers The skin samples were
quickly frozen and sliced into 6 mm thick cryostat sections. The sections
were stained with a 1% aqueous solution of safranin for 1 min and
£ooded with a 2% KOH solution by the method described by Ya Xian
et al (1999). Safranin produces a clear reddened intensi¢cation of the
intercellular portions of the SC even in the KOH solution. The number
of swollen corneocyte layers was counted at 10 locations per section,
avoiding the sites of follicular ostia, to obtain a mean.
Statistics Obtained values were represented as the mean with SEM.
Probability levels of po0.05 and p o 0.01 were considered signi¢cant
when the results were analyzed by the Student’s t test.
RESULTS
Induction of diabetes mellitus with streptozotocin and
alloxan All the mice developed diabetes rapidly after the
injections of streptozotocin 150 mg per kg (Table I). A signi¢-
cant increase in the blood glucose concentration was noted from
the second day after the injection, and the increase continued
time-dependently up to 3 wk. After 4 wk, the transaminase
activity of the diabetic mice was similar to that of the controls.
There was no increase in body weight during the 3 wk period
of streptozotocin induction (data not shown). The injection with
alloxan (45 mg per kg) also induced the rapid development of
diabetes with a signi¢cant increase in blood glucose concen-
tration observed from the second day after the injection. The
transaminase activity (glutamic-oxaloacetic transaminase and
glutamic-pyruvic transaminase), a marker for liver damage,
remained normal in the alloxan-treated mice for the ¢rst 2 wk,
then rose above the control level after week 3. This latter ¢nding
indicated that alloxan was more toxic than streptozotocin.
Changes in functional properties of the SC The strepto-
zotocin-treated mice showed a time-dependent decrease in the
high-frequency conductance of the SC compared with the
control group after the induction of diabetes (Fig 1A,C). In
contrast, there was no di¡erence in TEWL between the control
and streptozotocin groups during this induction phase (3 wk)
(Fig 1B,D). At 3 wk after the injection, high-frequency
conductance of the SC of the diabetic animals was half that of
the control group (Fig 1C). At this point, results of freeze-dry
weighing con¢rmed that the water content of the whole skin
was no lower in the streptozotocin group than in the control
group (control, 69.070.8%; streptozotocin, 71.370.5%; n¼ 5),
suggesting that the viable skin tissue in the former was not
dehydrated.
In the mice treated with alloxan, the high-frequency
conductance of the SC decreased signi¢cantly in the ¢rst 2 wk
after the injection (Fig 2A), but again there was no change in
TEWL (Fig 2B). These data de¢nitely indicated that the
decrease in the SC water content was not due to the direct toxic
e¡ect of streptozotocin or alloxan. They also suggested that the
experimentally induced diabetic mice had impaired water
homeostasis in the SC without any changes in the barrier
function. Moreover, we con¢rmed a similar decrease in the SC
water content in hairless rats (WBN/I 1a-Ht) 4 wk after
streptozotocin (40 mg per kg) injection [control, 34.0710.0 mS
(Siemens); streptozotocin,10.071.6 mS (Siemens); po 0.05 (n¼ 5)].
Changes in the amino acid content of the SC To examine
the mechanisms underlying the decreased hydration of the SC
in the mice with streptozotocin-induced diabetes, we quanti¢ed
the amino acids in the SC. In this diabetic group, the amino acid
content actually showed a slight increase 3 wk after the
streptozotocin injection (Fig 3A). According to immuno-
blotting analysis, the epidermal concentrations of pro¢laggrin
and ¢laggrin protein, the precursors of the water-soluble amino
acids, were almost unaltered in these animals (Fig 3B). These
results suggested that the normal metabolism of pro¢laggrin to
amino acids was functional in the epidermis of the streptozotocin-
induced diabetic mice.
Changes in the SC lipid content We analyzed the SC lipid
contents in the streptozotocin group.Whereas the total SC lipids
(per unit area) were higher in the streptozotocin group than in
the control group 3 wk after the injection (Table II), the SC
triglyceride content was signi¢cantly decreased after the induction
of diabetes. It was interesting to note that the ratios of ceramides
and cholesterol to the total lipids remained unchanged after the
induction of diabetes, whereas the ratio of triglycerides to the
total lipids decreased signi¢cantly, and the ratios of cholesterol-
wax ester and fatty acids to the total lipids both increased. This
change suggested that the triglycerides were being abnormally
metabolized in the sebaceous glands of the streptozotocin-
induced diabetic mice. Histochemical staining of skin with oil
red O, however, showed no special changes in the size or
number of sebaceous glands in the streptozotocin group (Fig 4).
Changes in the epidermal proliferation and corneocyte
surface area At 3 wk after the induction of diabetes, the
epidermis of the streptozotocin group was thinner than that of
the control group (streptozotocin, 22.270.8 mm vs control,
28.370.9 mm; n¼ 5, po 0.005). The ratio of PCNA-positive basal
Table I. E¡ects of diabetic induction on plasma glucose content and transaminase activity. Glucose content and transaminase activity
were measured at the indicated times after a single injection of diabetes-inducing agent or bu¡er.
Control Treated
Treatment Days after the injection Glucose (mg/dL) GOT (IU/L) GPT (IU/L) Glucose (mg/dL) GOT (U/L) GPT (IU/L)
STZ 2 days 21373.5 (5) N.D. N.D. 337722.6 (10)a N.D. N.D.
2 weeks 21473.9 (5) N.D. N.D. 567754.4 (10)a N.D. N.D.
3 weeks 21174.1 (5) N.D. N.D. 682731.2 (10)a N.D. N.D.
4 weeks 22178.7 (5) 2271.0 (5) 9.470.6 (5) 709733.4 (10)a 2472.3 (10)b 1171.2 (10)b
ALL 2 days 21573.7 (10) N.D. N.D. 689722.4 (20)a N.D. N.D.
2 weeks 21875.5 (10) 2771.8 (5) 1271.1 (5) 730716.2 (20)a 3473.8 (10)b 1471.7 (10)b
3 weeks 22073.0 (10) 2771.4 (5) 1070.7 (%) 811716.3 (20)a 6075.9 (10)b 1871.9 (10)a
Values represent mean with SEM CONTROL, bu¡er-injected group; STZ, streptozotocin induction (150 mg per kg); ALL, alloxan induction (45 mg per kg);
GOT, glutamic-oxaloacetic transaminase; GPT, glutanic-pyruvic transaminase.
aSigni¢cant di¡erence between diabetic and control groups (po 0.01).
bNo signi¢cant di¡erence between diabetic and control groups; ND, not determined; the number of animal per group is shown in parentheses.
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cells to the total basal cells in the epidermis was signi¢cantly lower
in the streptozotocin group than in the control (Fig 5), re£ecting
the decreased epidermal DNA content in the former (strepto-
zotocin, 23.472.1 mg per cm2 vs control, 29.370.6 mg per cm2;
Figure1. Mice with streptozotocin-induced diabetes show decreased water content of the SC without impairment of the water barrier func-
tion. High-frequency conductance (A,C) and TEWL (B,D) were measured at 2 wk (A,B) and 3 wk (C,D) after a single injection of streptozotocin (150mg
per kg). CONTROL, bu¡er-injected group; STZ, streptozotocin group. nSigni¢cant (po 0.05); N.S., not signi¢cant. Values represent mean with SEM
from ¢ve animals per group.
Figure 2. Mice with alloxan-induced diabetes show decreased water
content of the SC without impairment of the water barrier func-
tion. High-frequency conductance (A) and TEWL (B) were measured at
2 wk after a single injection of alloxan (45 mg per kg). CONTROL, buf-
fer-injected group; ALL, alloxan group. nnnSigni¢cant (po 0.001); N.S.,
not signi¢cant. Values represent mean with SEM from ¢ve animals per
group.
Figure 3. Streptozotocin-induced diabetic mice show normal ami-
no acid production in the SC. The amino acid content in the SC (A)
and epidermal (pro)¢laggrin content (B) were assayed at 3 wk after a single
injection of streptozotocin (150 mg per kg). CONTROL, bu¡er-injected
group; STZ, streptozotocin group. nSigni¢cant (po 0.05).Values represent
mean with SEM from ¢ve animals per group. FG shows ¢laggrin mono-
mer protein.
Table II. Streptozotocin-induced diabetes decreased triglyceride
content in the SC. The SC lipids were assayed at 3 wk after a single
injection of streptozotocin (150mg per kg).
The content was normalized to the surface area
Content (mg/cm2) (%)
Lipids Control STZ
Ceramide I 1.570.2 (1.670.2) 1.970.1a (1.670.1)c
Ceramide II-V 9.171.1 (10.071.6) 15.571.0b (12.971.2)c
Cholesterol 9.871.3 (10.871.6) 17.271.4b (14.170.9)c
Fatty acids 4.570.6 (5.070.8) 8.370.3b (6.870.3)a
Triglycerides 20.676.9 (24.377.5) 4.074.1a (3.473.5)a
Wax/Choresterol esters 22.671.0 (24.571.3) 41.073.3b (33.772.1)b
Total lipids 92.573.8 121.675.9b
CONTROL, bu¡er-injected group; STZ, streptozotocin group.
aSigni¢cant (po 0.05),
bsigni¢cant (po 0.005);
cnot signi¢cant.
Values represent mean with SEM from ¢ve animals per group.
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n¼ 5, po 0.05). The corneocyte surface area is reported to grow
in senile xerosis (Corcu¡ and Leveque, 1993; Hara et al, 1993) and
shrink in atopic xerosis (Watanabe et al, 1991), re£ecting the
epidermal turnover rate. The corneocyte surface area in the
streptozotocin group tended to increase above the control level
(Fig 6), with increases in the number of corneocyte layers in the
SC (control, 6.370.1 mg per cm2 vs streptozotocin, 7.370.4;
n¼ 5, po 0.05). These results suggested that the epidermal cell
turnover in the streptozotocin-induced diabetic mice progressed
at a slower rate.
Changes in the epidermal di¡erentiation Prompted by an
earlier report demonstrating an insulin-induced stimulation of
keratinocyte di¡erentiation in vitro (Wertheimer et al, 2000), we
decided to examine whether streptozotocin could induce any
changes in the epidermal di¡erentiation. In a comparison with
the control group by western blotting, we found no special
changes of the epidermal proteins, keratin 1, keratin 5, keratin 10,
and loricrin (58^90 kDa), in the streptozotocin animals (Fig 7A);
however, we found that three peptides (34 kDa, 36 kDa, and 43
kDa) observed only in the streptozotocin group (Fig 7B) cross-
reacted with anti-loricrin antibody in the SC proteins of the aged
mice.
DISCUSSION
In this study, we con¢rmed for the ¢rst time that experimentally
induced diabetic hairless mice showed de¢nite functional changes
in SC hydration together with alterations in the epidermal prolif-
eration. The decrease in SC water content was not accompanied
by impairment in the SC barrier function.The state of SC hydra-
tion is known to be regulated by three factors in the SC: the
water-soluble natural moisturizing factor (Horii et al, 1989), inter-
cellular lipids (Imokawa et al, 1991b), and sebum lipids (O’goshi
et al, 2000). The SC levels of amino acids (Horii et al, 1989; Denda
et al, 1992;Tanaka et al, 1998) and ceramides, the main components
of intercellular lipids (Imokawa et al, 1991a; Akimoto et al, 1993;
Yoshikawa et al, 1994), are reported to decrease in the dry skin
observed in the atopic dermatitis and aged skin. Dry skin of se-
nile xerosis is characterized also by signi¢cant decreases in trigly-
cerides (Hara et al, 1993). In this study, however, we have
demonstrated that the decreased water content in the SC of dia-
betic animals occurs independently of the changes in the sub-
stances of the SC, with the exception of the triglycerides. Thus,
the decreased water content in the SC is likely to be associated
with factors unrelated to the epidermal di¡erentiation. For exam-
ple, the reduced state of SC hydration may be elicited by the
Figure 5. The epidermis of mice with streptozotocin-induced dia-
betes shows decreased proliferation of basal cells. At 3 wk after a sin-
gle injection of streptozotocin (150 mg per kg), specimens were ¢xed and
immunostained using anti-PCNA antibody. PCNA-positive basal cells
were counted. CONTROL (A), bu¡er-injected group; STZ (B), streptozo-
tocin group. nnnSigni¢cant (po 0.001). Values represent mean with SEM
from four animals per group.
Figure 6. Surface areas of corneocytes in streptozotocin-induced
diabetic mouse. The corneocyte surface areas were measured 3 wk after
a single injection of streptozotocin (150 mg per kg), and also at indicated
ages (10, 36, 63 wk). CONTROL, bu¡er-injected group; STZ, streptozoto-
cin group. nnnSigni¢cant (po 0.001); nsigni¢cant (po 0.05). Values repre-
sent mean with SEM from ¢ve animals per group.
Figure 7. E¡ects of streptozotocin-induction on the di¡erentiation
marker proteins of the epidermis. At 3 wk after the induction, epider-
mal protein was extracted and applied to western blotting (A). Two micro-
grams [for keratin 1 (K1), keratin 5 (K5), and keratin 10 (K10)] or 20 mg (for
loricrin) of epidermal protein was loaded per lane. Lanes 1^5, bu¡er-in-
jected group; lanes 6^10, streptozotocin group. At the same time, the SC
protein was extracted and applied to western blotting using anti-loricrin
antibody (B). Twenty micrograms of SC protein was loaded per lane. Lanes
1 and 2, bu¡er-injected group (10 wk); lanes 3 and 4, streptozotocin group
(10 wk); lanes 5 and 6, normal mice (16 wk); lanes 7 and 8, normal mice
(48 wk); lanes 9 and 10, aged mice (80 wk).
Figure 4. Oil Red O stain of skin of streptozotocin-induced dia-
betic mice. At 3 wk after the streptozotocin induction, frozen sections
of mouse skin were stained using oil red O. (A) Bu¡er-injected group; (B)
streptozotocin group. Scale bar¼ 50 mm.
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hyperglycemic condition and/or the inhibition of the insulin sig-
nal transduction.
In our experiments, we could not ¢nd any impairment of pro-
¢laggrin processing or changes in di¡erentiation marker proteins
keratin 1, keratin 10, and loricrin in the epidermis of the diabetic
animals after streptozotocin treatment.
PKC isoforms are reported to be involved in the di¡erentiation
of keratinocytes (Lee et al, 1998; Takahashi et al, 1998). Keratino-
cytes contain diacylglycerol-activated PKC such as PKC-a, -d,
-e, and -Z (Reynolds et al, 1994; Mitev and Miteva, 1999), and
two of these PKC, PKC-a and -Z, are known to play an impor-
tant part in keratinocyte growth and di¡erentiation. Interestingly,
hyperglycemia has been reported to induce an increase in the dia-
cylglycerol content in various tissues, such as the retina, aorta,
heart, and glomeruli, thereby activating PKC isoforms (Koya
and King, 1998; Kang et al, 1999). Whereas it remains unknown
whether hyperglycemia activates PKC in keratinocytes as it does
in other tissues, our present results suggest that PKC is activated
under a hyperglycemic condition as well as during normal di¡er-
entiation. In any case, these points should be investigated further
in the future.
The processing of the SC protein may undergo changes in the
diabetic state similar to those noted in aged skin. Loricrin, a pro-
tein produced in the terminal di¡erentiation process to cross-link
immediately the corni¢ed envelope, is very di⁄cult to solubilize
(Candi et al, 1995). In fact, using the SC protein from normal
young mice, the peptides that cross-reacted with anti-loricrin
antibody were extremely di⁄cult to solubilize. Using SC pro-
teins from diabetic mice and aged mice, however, we found that
the loricrin-derived peptides could be easily solubilized, suggest-
ing that some sort of changes occurred in the maturation, proteo-
lysis, and/or oxidation stages of loricrin processing. This ¢nding
might have been due to a decreased turnover rate of the epidermis.
We noted that the streptozotocin-treated mice showed lower
proliferative activity of the epidermal basal cells and a reduced
epidermal DNA content, together with an increase in the num-
ber of corneocyte layers.We also found that the corneocytes were
larger in the diabetic animals than in the controls, suggesting that
the rates of turnover in both the epidermis and SC were retarded.
Similar alterations have been observed in aged human skin
(Grove and Kligman, 1983; Hara et al, 1993), and enlarged corneo-
cytes have been demonstrated in diabetic patients (Yajima et al,
1991). The attenuated insulin signal transduction has been specu-
lated to be important in the growth and di¡erentiation of kerati-
nocytes. Keratinocytes have constituent insulin receptor
(Wertheimer et al, 2000), and insulin stimulates keratinocyte mi-
gration (Benoliel et al, 1997) and proliferation (Tsao et al, 1982).
Recently,Wertheimer et al (2000) showed that insulin and insu-
lin-like growth factor also regulated the di¡erentiation of kerati-
nocytes. In experiments using insulin receptor null mice, the
same group also reported a reduced proliferation of epidermis
similar to that seen in our diabetic mice (Wertheimer et al, 2001).
On the other hand, another study on diabetic skin has shown a
downregulation in the expression of nerve growth factor, an
autocrine growth factor of keratinocytes (Anand et al, 1996), and
an upregulation in the expression of nerve growth factor recep-
tors (Terenghi et al, 1997). Thus, abnormal signal transduction of
insulin and/or nerve growth factor may also be related to the de-
creased epidermis turnover in our diabetic mouse model.
It has already been mentioned that the streptozotocin-induced
mice exhibited a signi¢cant decrease in the SC triglyceride con-
tent in parallel with an increase in wax/cholesterol esters. Interest-
ingly, this implies that there may be changes of the lipid
metabolism in the sebaceous glands. A similar decrease in the
SC triglycerides has been observed in aged human SC (Saint
LeŁ ger et al, 1989; Akimoto et al, 1993; Hara et al, 1993). Insulin is
reported to stimulate the synthesis of fat in the adipocytes
(Paulauskis and Sul, 1988; Jensen et al, 1989). Sztalryd and Kraemer
(1995) reported that hormone-sensitive lipase activity was stimu-
lated in the adipocytes of streptozotocin-induced diabetic rats.
The observed decrease of triglycerides in the SC may be due to
a similar activation of lipolysis in the sebaceous glands with a
consequential change in the sebum composition. A decrease of
triglycerides observed in senile xerosis patients (Hara et al, 1993)
does not rule out the important role of triglycerides in moistur-
izing the SC. It is well known that lipid extraction of the skin
surface with acetone induces a signi¢cant reduction in SC hydra-
tion, even if continued for only short time. In the seborrheic
areas, such as the face and scalp, however, this decreased SC
hydration returns to the pretreatment levels within a few hours
with a replenishment of skin surface lipids by sebum secretion
(Tagami, 1989; O’goshi et al, 2000). These reports indicate that se-
bum plays an important part in the regulation of the hydration
state of the skin surface. In contrast, there are some elderly per-
sons without any xerosis change despite the fact that their SC tri-
glyceride content is comparable with those of xerosis patients
(Akimoto et al, 1993).
Moreover, we cannot exclude the possibility that several here-
tofore unknown mechanisms unrelated to the e¡ects of amino
acids, intercellular lipids, and sebum in the SC have some invol-
vement in the decreased SC water content of this diabetic mouse
model. One such mechanism could be the involvement of a nat-
ural moisturizing factor.To date, few studies have investigated the
function of water-soluble substances other than the SC amino
acids in the regulation of the hydration state of the skin surface.
Another possible mechanism is the involvement of epidermal
water movement. Suzuki et al (1994) showed an increase in intra-
cellular hydration in nerve edema in diabetic rats, suggesting ab-
normal water movement in such a state. A chemiosmotic
alteration in the SC and/or keratinocytes beneath the SC layer
may impair the SC water homeostasis in diabetic mice. One can-
didate playing an important part in epidermal water movement is
aquaporin, an important water channel of various tissues, such as
the kidney, lung, retina, and cornea. Our group recently found
that aquaporin isoforms are expressed in the keratinocytes and
that aquaporin-3 is induced under hypertonic stress (Sugiyama
et al, 2001). Ma et al (2002) reported reduced SC hydration in the
hairless aquaporin-3 null mice. Taken together, these results sug-
gest that the epidermal water movement may be related to the
hydrated state of the SC.
It was interesting to note that the SC of the diabetic mice ex-
hibited four features also seen in senile xerosis: reduced SC hy-
dration, impaired turnover of the epidermis, accumulated
corneocyte layers, and decreased triglyceride content. Thus, hy-
perglycemia and/or attenuated insulin signal are thought to en-
hance the aging process of the skin. Another interesting ¢nding
is the discovery of insulin resistance in aging subjects and subjects
with Werner’s syndrome, which is a form of progeria (Izumino
et al, 1997; Kausch et al, 2000). Further, diabetes-like dermal changes
such as collagen glucosylation (Schnider and Kohn, 1980) and
elastic ¢ber abnormalities (Braverman and KehYen, 1984) are also
described in aged skin, suggesting that an attenuated insulin sig-
nal in diabetes may be partially involved in the aging process of
the skin. In this study we examine the skin of type 1 diabetes, but
it may be interesting to evaluate the phenotype of other diabetic
models (i.e., type 2 diabetic models). In future the evaluation of
the epidermal function of these models and diabetic patients will
reveal the relationship between the epidermal function and hy-
perglycemia or insulin signal transduction.
In conclusion, this study is the ¢rst to describe an impaired
water homeostasis in the SC of the experimental diabetic hairless
mouse. This model is useful for the study of diabetic dermopathy
as well as the mechanisms of SC moisturization.
REFERENCES
Akimoto K,Yoshikawa N, Higaki Y, Kawashima M, Imokawa G: Quantitative ana-
lysis of stratum corneum lipids in xerosis and asteatotic eczema. J Dermatol
20:1^6, 1993
Anand P,Terenghi G,Warner G, Kopelman P,Williams Chestnut RE, Sinicropi DV:
The role of endogenous nerve growth factor in human diabetic neuropathy.
Nat Med 2:703^707, 1996
84 SAKAI ETAL THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
AndoY, Jensen PJ: Epidermal growth factor and insulin-like growth factor I enhance
keratinocyte migration. J Invest Dermatol 100:633^639, 1993
Aoki Y,Yazaki K, Shirotori K,YanagisawaY, Oguchi H, Kiyosawa K, Furuta S: Stif-
fening of connective tissue in elderly diabetic patients: relevance to diabetic
nephropathy and oxidative stress. Diabetologia 36:79^83, 1993
Benoliel AM, Kahn Peries B, Imbert J,Verrando P: Insulin stimulates haptotactic mi-
gration of human epidermal keratinocytes through activation of NF-kappa B
transcription factor. J Cell Sci 110:2089^2097, 1997
Bitar MS: Glucocorticoid dynamics and impaired wound healing in diabetes melli-
tus. AmJ Pathol 152:547^554, 1998
Bligh EG, DyerWJ: A rapid method of total lipid extraction and puri¢cation. Can J
Biochem Physiol 37:911^917, 1959
Braverman IM, Keh Yen A: Ultrastructural abnormalities of the microvasculature
and elastic ¢bers in the skin of juvenile diabetics. J Invest Dermatol 82:270^274,
1984
Brown RL, Breeden MP, Greenhalgh DG: PDGF and TGF-alpha act synergistically
to improve wound healing in the genetically diabetic mouse. J Surg Res 56:562^
570, 1994
Candi E, Melino G, Mei G, Tarcsa E, Chung SI, Marekov LN, Steinert PM: Bio-
chemical, structural, and transglutaminase substrate properties of human lori-
crin, the major epidermal corni¢ed cell envelope protein. J Biol Chem
270:26382^26390, 1995
Cheta D: Animal models of type I (insulin-dependent) diabetes mellitus. J Pediatr
Endocrinol Metab 11:11^19, 1998
Collier A, Patrick AW, Bell D, Matthews DM, MacIntyre CC, Ewing DJ, Clarke BF:
Relationship of skin thickness to duration of diabetes, glycemic control,
and diabetic complications in male IDDM patients. Diabetes Care 12:309^312,
1989
Corcu¡ P, Leveque J-L: Size and shape of corneocytes at various body sites: In£uence
of age. In: Leveque J-L Agache PG, (eds). Aging Skin. NewYork: Marcel Dek-
ker, 1993: pp 199^216
Denda M, Hori J, Koyama J, et al: Stratum corneum sphingolipids and free amino
acids in experimentally-induced scaly skin. Arch Dermatol Res 284:363^367,
1992
Forst T, Kann P, Pfˇtzner A, Lobmann R, SchTfer H, Beyer J: Association between
‘‘diabetic thick skin syndrome’’ and neurological disorders in diabetes mellitus.
Acta Diabetol 31:73^77, 1994
Franzen LE, Roberg K: Impaired connective tissue repair in streptozotocin-induced
diabetes shows ultrastructural signs of impaired contraction. J Surg Res 58:407^
414, 1995
Grove GL, Kligman AM: Age-associated changes in human epidermal cell renewal.
J Gerontol 38:137^142, 1983
Hara M, Kikuchi K,Watanabe M, et al: Senile xerosis. functional, morphological, and
biochemical studies. J Geriatr Dermatol 1:111^120, 1993
Haratake A, Uchida Y, Schmuth M, et al: UVB-induced alterations in permeability
barrier function: roles for epidermal hyperproliferation and thymocyte-
mediated response. J Invest Dermatol 108:769^775, 1997
Horii I, NakayamaY, Obata M, Tagami H: Stratum corneum hydration and amino
acid content in xerotic skin. Br J Dermatol 121:587^592, 1989
Imokawa G, Abe A, Jin K, Higaki Y, Kawashima M, Hidano A: Decreased level of
ceramides in stratum corneum of atopic dermatitis: an etiologic factor in atopic
dry skin? J Invest Dermatol 96:523^526, 1991a
Imokawa G, Kuno H, Kawai M: Stratum corneum lipids serve as a bound-water
modulator. J Invest Dermatol 96:845^851, 1991b
Izumino K, Sakamaki H, Ishibashi M, et al: Troglitazone ameliorates insulin
resistance in patients with Werner’s syndrome. J Clin Endocrinol Metab 82:
2391^2395, 1997
Jelinek JE: The skin in diabetes. Diabet Med 10:201^213, 1993
Jensen MD, Caruso M, Heiling V, Miles JM: Insulin regulation of lipolysis in non-
diabetic and IDDM subjects. Diabetes 38:1595^1601, 1989
Kang N, Alexander G, Park JK, Maasch C, Buchwalow I, Luft FC, Haller H: Di¡er-
ential expression of protein kinase C isoforms in streptozotocin-induced dia-
betic rats. Kidney Int 56:1737^1750, 1999
Kausch C, Hamann A, Uphues I, et al: Association of impaired phosphatidylinositol
3-kinase activity in GLUT1-containing vesicles with malinsertion of glucose
transporters into the plasma membrane of ¢broblasts from a patient with se-
vere insulin resistance and clinical features of Werner syndrome. J Clin Endocri-
nol Metab 85:905^918, 2000
Kennedy L, Baynes JW: Non-enzymatic glycosylation and the chronic complications
of diabetes: an overview. Diabetologia 26:93^98, 1984
Koya D, King GL: Protein kinase C activation and the development of diabetic com-
plications. Diabetes 47:859^866, 1998
LeeYS,Yuspa SH, Dlugosz AA: Di¡erentiation of cultured human epidermal kerati-
nocytes at high cell densities is mediated by endogenous activation of the pro-
tein kinase C signaling pathway. J Invest Dermatol 111:762^766, 1998
Ma T, Hara M, Sougrat R, Verbavatz JM, Verkman AS: Impaired stratum corneum
hydration in mice lacking epidermal water channel aquaporin-3. J Biol Chem
5:5, 2002
MitevV, Miteva L: Signal transduction in keratinocytes. Exp Dermatol 8:96^108, 1999
Moore D: Preparation and analysis DNA. In: Ausubel FM, (ed.) Current Protocols in
Molecular Biology. NewYork: JohnWiley & Sons Inc., 1999: pp 2.0.1.^2.0.3.
Nikkels Tassoudji N, Henry F, Letawe C, Pierard Franchimont C, Lefebvre P, Pierard
GE: Mechanical properties of the diabetic waxy skin. Dermatology 192:19^22,
1996
Nishikawa T, Du Edelstein DXL, Yamagishi S, et al: Normalizing mitochondrial
superoxide production blocks three pathways of hyperglycaemic damage. Nat-
ure 404:787^790, 2000
O’goshi K, Iguchi M,Tagami H: Functional analysis of the stratum corneum of scalp
skin: studies in patients with alopecia areata and androgenic alopecia. Arch Der-
matol Res 292:605^611, 2000
Paulauskis JD, Sul HS: Cloning and expression of mouse fatty acid synthase and
other speci¢c mRNAs Developmental and hormonal regulation in 3T3-L1
cells. J Biol Chem 263:7049^7054, 1988
Reynolds NJ, Baldassare JJ, Henderson PA, et al: Translocation and downregulation
of protein kinase C isoenzymes-alpha and -epsilon by phorbol ester and
bryostatin-1 in human keratinocytes and ¢broblasts. J Invest Dermatol 103:364^
369, 1994
Saint LeŁ ger D, FrancX ois AM, LeŁ ve^que JL, Stoudemayer TJ, Kligman AM, Grove G:
Stratum corneum lipids in skin xerosis. Dermatologica 178:151^155, 1989
Schnider SL, Kohn RR: Glucosylation of human collagen in aging and diabetes
mellitus. J Clin Invest 66:1179^1181, 1980
Sternberg M, Cohen Forterre L, Peyroux J: Connective tissue in diabetes mellitus: bio-
chemical alterations of the intercellular matrix with special reference to proteo-
glycans, collagens and basement membranes. Diabetes Metab 11:27^50, 1985
SugiyamaY, OtaY, Hara M, Inoue S: Osmotic stress up-regulates aquaporin-3 gene
expression in cultured human keratinocytes. Biochim Biophys Acta 1522:82^88,
2001
Suzuki E, Yasuda K, Miyazaki S, Takeda N, Inouye H, Omawari N, Miura K: 1H-
NMR analysis of nerve edema in the streptozotocin-induced diabetic rat [see
comments]. J Lab Clin Med 124:627^637, 1994
Sztalryd C, Kraemer FB: Regulation of hormone-sensitive lipase in streptozotocin-
induced diabetic rats. Metabolism 44:1391^1396, 1995
Tagami H: Impedance measurement for evaluation of the hydration state of the skin
surface. In: Leveque J-L, (ed.) Cutaneous Investigation in Health and Disease. New
York: Marcel Dekker, 1989: pp 79^111
Tagami H, Ohi M, Iwatsuki K, KanamaruY,Yamada M, Ichijo B: Evaluation of the
skin surface hydration in vivo by electrical measurement. J Invest Dermatol
75:500^507, 1980
Takahashi H, Asano K, Manabe A, Kinouchi M, IshidaYamamoto A, Iizuka H: The
alpha and eta isoforms of protein kinase C stimulate transcription of human
involucrin gene. J Invest Dermatol 110:218^223, 1998
Tanaka M, Okada M, ZhenYX, et al: Decreased hydration state of the stratum cor-
neum and reduced amino acid content of the skin surface in patients with sea-
sonal allergic rhinitis. Br J Dermatol 139:618^621, 1998
Terenghi G, Mann D, Kopelman PG, Anand P: trkA and trkC expression is in-
creased in human diabetic skin. Neurosci Lett 228:33^36, 1997
Tomlinson KC, Gardiner SM, Hebden RA, Bennett T: Functional consequences of
streptozotocin-induced diabetes mellitus, with particular reference to the car-
diovascular system. Pharmacol Rev 44:103^150, 1992
Tsao MC,Walthall BJ, Ham RG: Clonal growth of normal human epidermal kera-
tinocytes in a de¢ned medium. J Cell Physiol 110:219^229, 1982
Watanabe M,Tagami H, Horii I,Takahashi M, Kligman AM: Functional analyses of the
super¢cial stratum corneum in atopic xerosis. Arch Dermatol 127:1689^1692, 1991
Wertheimer E, Trebicz M, Eldar T, Gartsbein M, Nofeh Moses S, Tennenbaum T:
Di¡erential roles of insulin receptor and insulin-like growth factor-1 receptor
in di¡erentiation of murine skin keratinocytes. J Invest Dermatol 115:24^29, 2000
Wertheimer E, Spravchikov N,Trebicz M, et al: The regulation of skin proliferation
and di¡erentiation in the IR null mouse: implications for skin complications
of diabetes. Endocrinology 142:1234^1241, 2001
Wilson GL, Leiter EH: Streptozotocin interactions with pancreatic beta cells and the
induction of insulin-dependent diabetes. CurrTop Microbiol Immunol 156:27^54,
1990
Ya Xian Z, Suetake T, Tagami H: Number of cell layers of the stratum corneum in
normal skinYrelationship to the anatomical location on the body, age, sex and
physical parameters. Arch Dermatol Res 291:555^559, 1999
Yajima Y, Sueki H, Fujisawa R: [Increased corneocyte surface area in the diabetic
skin]. Nippon Hifuka Gakkai Zasshi 101:129^134, 1991
Yoshikawa N, Imokawa G, Akimoto K, Jin K, Higaki Y, Kawashima M: Regional
analysis of ceramides within the stratum corneum in relation to seasonal
changes. Dermatology 188:207^214, 1994
STRATUM CORNEUM IN DIABETIC MICE 85VOL. 120, NO. 1 JANUARY 2003
